• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

获取医疗服务的成本-效用：国家艾滋病毒联系、重新参与和保持医疗服务

Cost-Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program.

机构信息

Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Room 904C, Baltimore, MD, 21205, USA.

AIDS United, 1424 K Street, N.W., Washington, DC, 20005, USA.

出版信息

AIDS Behav. 2018 Nov;22(11):3734-3741. doi: 10.1007/s10461-017-2015-z.

DOI:10.1007/s10461-017-2015-z
PMID:29302844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6034976/
Abstract

Linkage to HIV medical care and on-going engagement in HIV medical care are vital for ending the HIV epidemic. However, little is known about the cost-utility of HIV linkage, re-engagement and retention (LRC) in care programs. This paper presents the cost-utility analysis of Access to Care, a national HIV LRC program. Using standard methods from the US Panel on Cost-Effectiveness in Health and Medicine, we calculated the cost-utility ratio. Seven Access to Care programs were cost-effective and two were cost-saving. This study adds to a small but growing body of evidence to support the cost-effectiveness of LRC programs.

摘要

将艾滋病毒患者与医疗服务联系起来并持续参与艾滋病毒医疗服务对于终结艾滋病疫情至关重要。然而，人们对艾滋病毒患者的联系、重新参与和保留（LRC）护理方案的成本效益知之甚少。本文介绍了 Access to Care，一项全国性艾滋病毒 LRC 方案的成本效益分析。我们使用美国卫生与医疗保健成本效益小组的标准方法计算了成本效益比。有七个 Access to Care 方案具有成本效益，有两个方案具有成本节约效果。这项研究增加了支持 LRC 方案具有成本效益的少量但不断增长的证据。

相似文献

1
Cost-Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program.获取医疗服务的成本-效用：国家艾滋病毒联系、重新参与和保持医疗服务
AIDS Behav. 2018 Nov;22(11):3734-3741. doi: 10.1007/s10461-017-2015-z.
2
Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge.来自“积极充电”项目的美国三项艾滋病毒护理联系与重新参与护理计划的成本效用分析
AIDS Behav. 2016 May;20(5):973-6. doi: 10.1007/s10461-015-1243-3.
3
Cost and threshold analysis of positive charge, a multi-site linkage to HIV care program in the United States.美国一项针对艾滋病病毒护理项目的多地点联动——阳性电荷的成本与阈值分析
AIDS Behav. 2015 Oct;19(10):1735-41. doi: 10.1007/s10461-015-1124-9.
4
The Cost and Threshold Analysis of Retention in Care (RiC): A Multi-Site National HIV Care Program.持续接受治疗（RiC）的成本与阈值分析：一项多地点全国性艾滋病护理项目
AIDS Behav. 2017 Mar;21(3):643-649. doi: 10.1007/s10461-016-1623-3.
5
Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention.监狱后加强与艾滋病毒护理联系的成本分析：一种具有成本效益的干预措施。
AIDS Behav. 2013 Oct;17 Suppl 2(0 2):S220-6. doi: 10.1007/s10461-012-0353-4.
6
Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive.为澳大利亚的 HIV 阳性临时居民提供抗逆转录病毒治疗资金可预防传播且成本低廉。
Sex Health. 2018 Feb;15(1):13-19. doi: 10.1071/SH16237.
7
A Mixed-Methods Exploration of the Needs of People Living with HIV (PLWH) Enrolled in Access to Care, a National HIV Linkage, Retention and Re-Engagement in Medical Care Program.一项关于接受关爱项目（全国艾滋病毒关联、保留和重新参与医疗保健项目）的艾滋病毒感染者（PLWH）的需求的混合方法探索。
AIDS Behav. 2018 Mar;22(3):819-828. doi: 10.1007/s10461-017-1809-3.
8
Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs.美国12个创新性HIV关联及治疗留存项目的成本与成本阈值分析
AIDS Care. 2016 Sep;28(9):1199-204. doi: 10.1080/09540121.2016.1164294. Epub 2016 Mar 28.
9
Understanding the variation in costs among HIV primary care providers.了解艾滋病病毒初级护理提供者之间的成本差异。
AIDS Care. 2008 Oct;20(9):1050-6. doi: 10.1080/09540120701854626.
10
Barriers and Facilitators to the Implementation of a National HIV Linkage, Re-Engagement, and Retention in Care Program.国家艾滋病病毒关联、重新参与及护理留存项目实施的障碍与促进因素
AIDS Educ Prev. 2017 Oct;29(5):443-456. doi: 10.1521/aeap.2017.29.5.443.

引用本文的文献

1
"They treat us equally, they guide us": peer navigation for HIV care linkage in men who have sex with men and transgender women in Lima, Peru.“他们平等对待我们，他们指导我们”：秘鲁利马男男性行为者和跨性别女性艾滋病毒护理衔接中的同伴导航。
Rev Peru Med Exp Salud Publica. 2024 Aug 19;41(2):105-113. doi: 10.17843/rpmesp.2024.412.13198.
2
Costs and cost-effectiveness of a collaborative data-to-care intervention for HIV treatment and care in the United States.美国合作数据至护理干预措施在艾滋病毒治疗和护理方面的成本和成本效益。
J Int AIDS Soc. 2023 Jan;26(1):e26040. doi: 10.1002/jia2.26040.
3
Cost-Effectiveness of HIV Retention and Re-engagement Interventions in High-Income Countries: A Systematic Literature Review.高收入国家提高 HIV 患者保留率和重新参与治疗干预措施的成本效益：系统文献回顾。
AIDS Behav. 2022 Jul;26(7):2159-2168. doi: 10.1007/s10461-021-03561-w. Epub 2022 Jan 25.
4
The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review.高收入国家集中流行地区艾滋病毒/性传播感染预防的成本效益：范围综述。
AIDS Behav. 2022 Jul;26(7):2279-2298. doi: 10.1007/s10461-022-03583-y. Epub 2022 Jan 15.
5
Outcomes and costs of publicly funded patient navigation interventions to enhance HIV care continuum outcomes in the United States: A before-and-after study.美国公共资助的患者导航干预对改善 HIV 护理连续结局的效果和成本：一项前后对照研究。
PLoS Med. 2021 May 13;18(5):e1003418. doi: 10.1371/journal.pmed.1003418. eCollection 2021 May.
6
The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach.纽约市感染艾滋病毒的老年人一生中心理健康治疗的成本效益：一种马尔可夫方法。
Pharmacoecon Open. 2021 Jun;5(2):221-236. doi: 10.1007/s41669-020-00238-3. Epub 2020 Nov 9.
7
Cumulative Effects of Stigma Experiences on Retention in HIV Care Among Men and Women in the Rural Southeastern United States.美国东南部农村地区男男性行为者和女性 HIV 感染者经历污名对其坚持接受 HIV 护理的累积影响
AIDS Patient Care STDS. 2020 Nov;34(11):484-490. doi: 10.1089/apc.2020.0144.

本文引用的文献

1
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐：第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
2
Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds.理解并提高人均GDP的一倍和三倍成本效益阈值。
Health Policy Plan. 2017 Feb;32(1):141-145. doi: 10.1093/heapol/czw096. Epub 2016 Jul 24.
3
Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs.美国12个创新性HIV关联及治疗留存项目的成本与成本阈值分析
AIDS Care. 2016 Sep;28(9):1199-204. doi: 10.1080/09540121.2016.1164294. Epub 2016 Mar 28.
4
Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge.来自“积极充电”项目的美国三项艾滋病毒护理联系与重新参与护理计划的成本效用分析
AIDS Behav. 2016 May;20(5):973-6. doi: 10.1007/s10461-015-1243-3.
5
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.加拿大不列颠哥伦比亚省针对艾滋病毒的人群层面扩大高效抗逆转录病毒治疗的成本效益：一项建模研究。
Lancet HIV. 2015 Sep;2(9):e393-400. doi: 10.1016/S2352-3018(15)00127-7. Epub 2015 Jul 16.
6
Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.曼谷男男性行为者中艾滋病毒治疗的扩大化：模型和成本研究。
Lancet HIV. 2015 May;2(5):e200-7. doi: 10.1016/S2352-3018(15)00020-X. Epub 2015 Mar 29.
7
Identifying Best Practices for Increasing Linkage to, Retention, and Re-engagement in HIV Medical Care: Findings from a Systematic Review, 1996-2014.确定增加与艾滋病毒医疗护理的联系、留存率和重新参与的最佳做法：1996 - 2014年系统评价的结果
AIDS Behav. 2016 May;20(5):951-66. doi: 10.1007/s10461-015-1204-x.
8
The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States.改善美国艾滋病病毒检测、关联及治疗留存率的流行病学和经济影响
Clin Infect Dis. 2016 Jan 15;62(2):220-229. doi: 10.1093/cid/civ801. Epub 2015 Sep 11.
9
Cost and threshold analysis of positive charge, a multi-site linkage to HIV care program in the United States.美国一项针对艾滋病病毒护理项目的多地点联动——阳性电荷的成本与阈值分析
AIDS Behav. 2015 Oct;19(10):1735-41. doi: 10.1007/s10461-015-1124-9.
10
Human immunodeficiency virus transmission at each step of the care continuum in the United States.美国关爱连续体各环节中的人类免疫缺陷病毒传播。
JAMA Intern Med. 2015 Apr;175(4):588-96. doi: 10.1001/jamainternmed.2014.8180.